Author

Rosline Hassan

Universiti Sains Malaysia - Cited by 3,221 - Hematopathology - Stem cell

Biography

Dr.Rosline Hassan is a Consultant hematopathologist Hospital from University Sains, Kota Bharu, since 1997, and Head of the department of hematology & transfusion medicine unit. from University Sains, since 2003. Dr.Rosline Hassan completed Technology assessor Master of Science International Organization for Standardization 15189, since 2003. Her research intrests reflect in her wide range of publications in various national and international journals.She is a Committee member Sekolah Rendah Kebangsaan Zainabl, Kelantan, 2005—2006, Fellow: College Pathologist, Academy Medicine and in Malaysian Society Blood Transfusion (life), Malaysian Society Haematology (life). Achievements include research in genetic in leukaemia, transfusion medicine, thalassaemia, coagulation
Title
Cited by
Year
Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients
MA Islam, S Kundu, SS Alam, T Hossan, MA Kamal, R HassanPloS one 16 (4), e0249788, 2021202
112
2021
Hypomethylating agents and immunotherapy: therapeutic synergism in acute myeloid leukemia and myelodysplastic syndromes
KK Wong, R Hassan, NS YaacobFrontiers in Oncology 11, 624742, 2021202
19
2021
High-dose vitamin C for cancer therapy
A Mussa, RA Mohd Idris, N Ahmed, S Ahmad, AH Murtadha, ...Pharmaceuticals 15 (6), 711, 2022202
17
2022
A global mutational profile of SARS-CoV-2: a systematic review and meta-analysis of 368,316 COVID-19 patients
W Yusof, AA Irekeola, Y Wada, ENS Engku Abd Rahman, N Ahmed, ...Life 11 (11), 24, 2021202
12
2021
A performance assessment study of different clinical samples for rapid COVID-19 antigen diagnosis tests
N Ahmed, MNA Kalil, W Yusof, MAA Bakar, AS Sjahid, R Hassan, ...Diagnostics 12 (4), 847, 2022202
11
2022
Performance validation of COVID-19 self-conduct buccal and nasal swabs RTK-antigen diagnostic Kit
MNA Kalil, W Yusof, N Ahmed, MH Fauzi, MAA Bakar, AS Sjahid, ...Diagnostics 11 (12), 2245, 2021202
10
2021
The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
YC Chia, MA Islam, P Hider, PY Woon, MF Johan, R Hassan, M RamliCancers 13 (12), 3078, 2021202
9
2021
Impact of biochar on the growth and physiology of tomato grown in the cadmium contaminated soil
K Dad, M Nawaz, R Hassan, K Javed, A Shaheen, F Zhao, M Imran, ...Pak. J. Agric. Res 34, 454-42, 2021202
6
2021
Molecular genetics of thrombotic myeloproliferative neoplasms: Implications in precision oncology
YC Chia, MJ Siti Asmaa, M Ramli, PY Woon, MF Johan, R Hassan, ...Diagnostics 13 (1), 13, 2023202
6
2023
Clinical and laboratory features of JAK2 V617F, CALR, and MPL mutations in malaysian patients with classical myeloproliferative neoplasm (MPN)
Clinical and laboratory features of JAK2 V17F, CALR, and MPL mutations in malaysian patients with classical myeloproliferative neoplasm (MPN)RH Zulkeflee, Z Zulkafli, MF Johan, A Husin, MA Islam, R HassanInternational journal of environmental research and public health 18 (14), 7582, 2021202
6
2021
The role of epigenetics in the development and progression of multiple myeloma
NH Ismail, A Mussa, NA Zakaria, MJ Al-Khreisat, MA Zahidin, NN Ramli, ...Biomedicines 10 (11), 2767, 2022202
4
2022
Non-compliance to iron chelation therapy in patients with transfusion-dependent thalassaemia
ASC Chai, N Draman, SSM Yusoff, NF Azman, MM Zulkifli, NM Yaacob, ...Pediatric Hematology Oncology Journal 6 (), 207-215, 2021202
4
2021
A novel algorithm using cell population data (VCS Parameters) as a screening discriminant between alpha and beta thalassemia traits
A Ambayya, S Sahibon, TW Yang, QY Zhang, R Hassan, J SatharDiagnostics 11 (11), 2163, 2021202
4
2021
Classification system for leukemia cell images based on hu moment invariants and support vector machines
Y Jusman, S Riyadi, A Faisal, SNAM Kanafiah, Z Mohamed, R Hassan2021 11th IEEE International Conference on Control System, Computing and …, 2021202
4
2021
Clinical implications of conventional cytogenetics, fluorescence in situ hybridization (FISH) and molecular testing in chronic myeloid leukaemia patients in the tyrosine kinase …
R Ankathil, SM Ismail, N Mohd Yunus, S Sulong, A Husin, AD Abdullah, ...Malays J Pathol 42 (), 07-21, 2020202
3
2020
Geospatial Analyses of Thyroid Cancer Incidence in Kelantan, Malaysia.
NFM Zuhdi, W Rahman, TA Damitri, AF Ismail, R HassanInternational Journal of Geoinformatics 17 (5), 010
2
2021
Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment …
I Siti Mariam, R Norhidayah, AB Zulaikha, MY Nazihah, H Rosline, ...Frontiers in Oncology 1, 70845, 0
2
2022
The Effects of Tamoxifen on Tolerogenic Cells in Cancer
RA Mohd Idris, A Mussa, S Ahmad, MAI Al-Hatamleh, R Hassan, ...Biology 11 (8), 15, 0
2
2022
The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
The Immunosuppressive Effect of TNFR Expression in the Colorectal Cancer MicroenvironmentNH Mohd Salim, A Mussa, N Ahmed, S Ahmad, C Yean Yean, R Hassan, ...Biomedicines 11 (1), 173, 030
2
2023
Prevalence and distribution of major β-thalassemia mutations and HbE/β-thalassemia variant in Nepalese ethnic groups
R Lama, W Yusof, TR Shrestha, S Hanafi, M Bhattarai, R Hassan, ...Hematology/oncology and stem cell therapy, 010
2
2021

Referred From: https://scholar.google.com.my/citations?user=-h0f6tYAAAAJ&hl=en

Cited by
Citations 3221
h-index 29
i10-index 82
Recommended Journals
Open Access Journals